<DOC>
	<DOCNO>NCT01424163</DOCNO>
	<brief_summary>This single multiple dose , open-label study evaluate pharmacokinetics ( PK ) , safety , tolerability dexpramipexole administer orally adult Japanese Caucasian healthy subject .</brief_summary>
	<brief_title>Dexpramipexole Japanese PK Study</brief_title>
	<detailed_description>The study design evaluate influence ethnic factor dexpramipexole safety , tolerability , PK . Subjects admit clinical unit Day -1 ( day prior first dose ) remain clinical unit observation discharge . All subject final follow visit . Whilst resident clinic , subject receive 4 treatment : The first 3 treatment comprise Part A study final treatment group comprise Part B . Part A : Treatment 1 : Dose 1 ( reduce ) dexpramipexole ; single dose Treatment 2 : Dose 2 ( standard ) dexpramipexole ; single dose Treatment 3 : Dose 3 ( standard ) dexpramipexole ; 5 dos administer 12 hour interval Part B : Dose 4 ( standard ) dexpramipexole ; 5 dos administer 12 hour interval There minimum washout 3 day treatment . For subject , prior proceed next treatment group , safety tolerability data review . Caucasian subject match individually ( 1:1 basis ) Japanese subject respect gender age possible BMI .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Subjects able willing give write informed consent . Adult Japanese Caucasian males/females age 18 60 year inclusive 18 30 kg/m2 body mass index ( BMI ) , inclusive . Male female subject enrol study . Male subject female subject childbearing potential , must practice effective contraception study willing able continue contraception 1 month ( female ) 3 month ( male ) last dose study treatment Japanese subject must bear Japan parent four grandparent Japanese descent . Japanese subject must live outside Japan 5 year . Japanese subject must significant change regard diet ; i.e. , diet must significantly change since leave Japan . Caucasian subject match individually ( 1:1 basis ) Japanese subject respect gender age , possible BMI . Subjects conform inclusion criterion . Female subject pregnant , try become pregnant lactating . Subjects clinically relevant history presence respiratory , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue diseases disorder . Subjects clinically relevant surgical history . Subjects previously receive dexpramipexole pramipexole .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>